03 October 2022 : Clinical Research
Effect of Vitamin D Concentration on Course of COVID-19
Magdalena Dominika Szerszeń12ABDEF*, Aleksandra Kucharczyk3BDEF, Katarzyna Bojarska-Senderowicz3BDEF, Monika Pohorecka32ADEF, Andrzej Śliwczyński4CD, Janusz Engel5C, Tomasz Korcz6B, Dariusz Kosior7A, Irena Walecka8A, Wojciech Stefan Zgliczyński9A, Waldemar Wierzba1011G, Adam Jerzy Sybilski32ADFDOI: 10.12659/MSM.937741
Med Sci Monit 2022; 28:e937741
Table 1 Vitamin D level in the study population.
| Vitamin D level | COVID-19 (+) | COVID-19 (−) | ||||
|---|---|---|---|---|---|---|
| Male | Female | Total | Male | Female | Total | |
| Optimal (>30 ng/ml) | 11 | 25 | 36 (19.4%) | 26 | 39 | 65 (20.4%) |
| Suboptimal (20–30 ng/ml) | 6 | 26 | 32 (17.2%) | 39 | 32 | 71 (22.3%) |
| Deficiency (<20 ng/ml) | 76 | 42 | 118 (63.4%) | 98 | 85 | 183 (57.4%) |